Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Celsius Reports $522.3M Pro Forma Adjusted EBITDA

Celsius Holdings Inc. has reported its financial results for the period ending June 30, 2025. The company's non-GAAP EBITDA stood at $318.8 million, with adjustments including stock-based compensation of $22.7 million, acquisition and reorganization costs of $47.4 million, legal settlement costs of $54.0 million, foreign exchange gains or losses of ($0.6) million, penalties of $10.1 million, and inventory step-up adjustments of $21.7 million. Additionally, the company realized $48.2 million in unrealized synergies.

The Pro Forma Adjusted EBITDA for the same period was reported at $522.3 million, reflecting an increase from the non-GAAP Adjusted EBITDA. This figure accounts for the unrealized synergies and provides a more comprehensive view of the company's performance.

It is worth noting that the company's financial results are reported in compliance with the generally accepted accounting principles in the United States (GAAP). However, management believes that the disclosure of Adjusted EBITDA and Adjusted EBITDA Margin, non-GAAP financial measures, provides additional insights into operating performance.

These figures indicate the company's efforts to manage and optimize its operating results by making adjustments in various areas, including stock-based compensation, acquisition and reorganization costs, legal settlement costs, foreign exchange gains or losses, penalties, and inventory step-up adjustments, ultimately contributing to the overall performance reflected in the Pro Forma Adjusted EBITDA. As a result of these announcements, the company's shares have moved -0.83% on the market, and are now trading at a price of $54.73. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS